A quicker and cheaper technique to scan molecular databases developed at the Department of Energy's Oak Ridge National Laboratory could put scientists on the fast track to developing new drug treatments
Data from a number of in vitro models can be combined to assess the potential for molecules to penetrate the blood-brain barrier (BBB) and cause an effect in the CNS.